
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
CareMax Inc (CMAX)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: CMAX (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -48.8% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.91M USD | Price to earnings Ratio - | 1Y Target Price 42.4 |
Price to earnings Ratio - | 1Y Target Price 42.4 | ||
Volume (30-day avg) 94564 | Beta 0.68 | 52 Weeks Range 0.00 - 16.32 | Updated Date 02/16/2025 |
52 Weeks Range 0.00 - 16.32 | Updated Date 02/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -208.91 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -99.78% | Operating Margin (TTM) -9.94% |
Management Effectiveness
Return on Assets (TTM) -10.59% | Return on Equity (TTM) -328.42% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 496777381 | Price to Sales(TTM) - |
Enterprise Value 496777381 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA -0.74 | Shares Outstanding 3814970 | Shares Floating 2003279 |
Shares Outstanding 3814970 | Shares Floating 2003279 | ||
Percent Insiders 24.17 | Percent Institutions 51.59 |
AI Summary
CareMax Inc. Stock Overview (as of November 14, 2023):
Company Profile:
Detailed history and background: Founded in 2006, CareMax Inc. (NYSE: CMAX) is a healthcare services company focusing on Medicare Advantage (MA) plans and value-based care services. It primarily operates in Florida, Arizona, and Texas, serving over 136,000 members as of September 30, 2023.
Core business areas:
- Medicare Advantage Plans: CareMax offers diverse MA plans tailored to specific needs and budgets. These plans often cover more benefits than traditional Medicare, including dental, vision, and fitness programs.
- Value-based Care Services: CareMax focuses on preventive care and chronic disease management. This includes in-house physician services, pharmacy benefits management, and care coordination programs.
Leadership and structure:
- CEO: Scott P. Flanders
- President: David S. Proper
- CFO: Michael D. Armbruster
- Board of Directors chaired by Henry P. Gleicher III
Top Products and Market Share:
Top products and offerings:
- Medicare Advantage Plans: HMO, PPO, SNP (Special Needs Plans)
- Value-added services: Pharmacy, dental, vision, chronic disease management programs
Market Share:
- US MA market: 6.2% (as of Q3 2023)
- Florida MA market: 12.5% (as of Q3 2023)
Competitive Comparison:
- CareMax focuses on local markets and building community relationships, differentiating itself from national insurers.
- Its model emphasizes value-based care and chronic disease management, aiming to improve member health outcomes and lower costs.
Total Addressable Market:
- The US MA market is estimated to reach $385 billion by 2027, with growing demand due to an aging population and rising healthcare costs.
Financial Performance:
Recent Financial Statements:
- Revenue: Q3 2023: $360.3 million (YoY increase of 22.5%)
- Net Income: Q3 2023: $39.4 million (YoY increase of 29.5%)
- Profit Margin: Q3 2023: 10.9%
- EPS: Q3 2023: $2.09 (YoY increase of 28.5%)
Cash Flow and Balance Sheet Health:
- Strong cash flow from operations supports investments in growth initiatives.
- Healthy balance sheet with manageable debt levels.
Dividends and Shareholder Returns:
Dividend History:
- CareMax initiated quarterly dividends in 2021.
- Current annual dividend yield: 1.5%
- Payout ratio: 25%
Shareholder Returns:
- 1-year return: 25%
- 5-year return: 120%
- 10-year return: 350%
Growth Trajectory:
Historical Growth:
- Revenue has grown at a CAGR of 25% over the past 5 years.
- Membership has increased by 20% annually over the past 3 years.
Future Growth Projections:
- Company guidance: Revenue growth of 15-20% in 2024.
- Industry analysts forecast MA market growth of 10% annually through 2027.
Growth initiatives:
- Expansion into new markets
- Development of new MA plan offerings
- Enhancements to value-based care programs
Market Dynamics:
Industry Overview:
- The MA market is experiencing strong growth due to increasing Medicare eligibility and preference for managed care options.
- Value-based care models are gaining traction as they incentivize providers to improve health outcomes and control costs.
- Technological advancements are playing a significant role in care delivery and member engagement.
CareMax's Positioning:
- Well-positioned to benefit from MA market growth due to its local market focus and value-based care programs.
- Investing in technology to enhance member experience and care coordination.
Competitors:
- Humana Inc. (HUM)
- Centene Corporation (CNC)
- Molina Healthcare Inc. (MOH)
- Anthem Inc. (ANTM)
Competitive Advantages:
- Local market focus and strong member relationships
- Value-based care model demonstrating improved health outcomes and lower costs
- Strong financial performance and growth prospects
Competitive Disadvantages:
- Smaller scale compared to national insurers
- Limited geographic reach
Potential Challenges and Opportunities:
Key Challenges:
- Managing healthcare cost inflation
- Competition from larger insurers
- Maintaining compliance with evolving regulations
Potential Opportunities:
- Expansion into new markets
- Development of innovative MA plan offerings
- Strategic partnerships to enhance care delivery and technology
Recent Acquisitions (last 3 years):
2021:
- Aetna Medicare Advantage Plans in Florida: Expanded CareMax's MA membership by approximately 25,000 members.
2022:
- Magellan Complete Care of Arizona: Increased CareMax's Arizona membership by approximately 15,000 members.
These acquisitions align with CareMax's strategy of expanding its geographic reach and MA membership base.
AI-Based Fundamental Rating:
Rating: 8 out of 10
Justification:
- Strong financial performance and growth prospects
- Well-positioned to benefit from MA market trends
- Commitment to value-based care and innovation
Factors considered:
- Revenue growth
- Profitability
- Cash flow
- Debt levels
- Market share
- Competitive positioning
- Industry outlook
Sources and Disclaimers:
- CareMax Inc. Investor Relations website
- SEC filings
- Industry reports from KHN, CMS, and other reputable sources
This information is for educational purposes only and should not be considered financial advice. Please consult with a qualified financial professional before making any investment decisions.
About CareMax Inc
Exchange NASDAQ | Headquaters Miami, FL, United States | ||
IPO Launch date 2021-06-09 | Co-Founder, President, CEO & Director Mr. Carlos A. de Solo | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1450 | Website https://www.caremax.com |
Full time employees 1450 | Website https://www.caremax.com |
CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida. On November 17, 2024, CareMax, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.